Ohio Public Employees Retirement System (OPERS)’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,300
Closed -$44.2K 2349
2025
Q3
$44.2K Buy
+24,300
New +$39.3K ﹤0.01% 1972

Other funds holding NMRA

Ohio Public Employees Retirement System (OPERS)'s NMRA Position: Q4 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Neumora Therapeutics (NMRA) in Q4 2025, closing a stake of 24,300 shares — an estimated $44.2K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in NMRA in Q3 2025 and held it in 1 quarter. The position peaked at $44.2K in Q3 2025. 102 funds tracked by Wall St. Rank hold NMRA as of Q4 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Neumora Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 24,300 Neumora Therapeutics shares in Q4 2025, an estimated $44.2K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Neumora Therapeutics in Q3 2025 and held it in 1 quarter.
  • Ohio Public Employees Retirement System (OPERS)'s Neumora Therapeutics position peaked at $44.2K in Q3 2025.
  • 102 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q4 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2025, filed 17 Feb 2026.